Intermittent administration of nicotinamide mononucleotide (NMN) by IV drip!
Tokyo Ginza Wellness & Aging Clinic (location: Chuo-ku, Tokyo; Director: Takahiro Otani) has launched the world's first clinical study to...
top of page
mirailabbio
- Jun 10, 2022
- 1 min
Lecture on the occasion of the opening of Tokyo Ginza Wellness & Aging Clinic
Shin-ichiro Imai, Director of the Group, gave a conference entitled "Exploring the Future of Anti-Aging Medicine: Cutting Edge of...
31 views
mirailabbio
- Jun 10, 2022
- 1 min
Professor Shin-Ichiro Imai, Director of Mirai Medical Group, receives prestigious title
Mirailab Bioscience, Inc. has been recognized for its significant contributions, including donations to anti-aging research at Washington...
71 views
mirailabbio
- Jun 10, 2022
- 1 min
Method to obtain anti-aging effects and method to determine aging degree using eNAMPT-EVs
Tokyo Ginza Wellness & Aging Clinic has welcomed a researcher from the Institute for Research on Productive Aging (IRPA; Representative...
83 views
mirailabbio
- Jun 10, 2022
- 1 min
Announcement of OIST Partner Agreement
We are pleased to announce that Miraikai Medical Corporation/Tokyo Ginza Wellness & Aging Clinic have signed a partnership agreement with...
45 views
mirailabbio
- Jun 10, 2022
- 1 min
World's first! NAD measurement at a private medical institution
The Tokyo Ginza Wellness & Aging Clinic of Mirai Medical Group have achieved the measurement of nicotinamide adenine dinucleotide (NAD)...
39 views
mirailabbio
- Jun 10, 2022
- 1 min
The University of Tokyo announces that NMN improves motor functions
The research group formed by Assistant Professor Masaki Igarashi, Dr. Yoshiko Nakagawa, Dr. Masaomi Miura, and Professor Toshimasa...
25 views
bottom of page